{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:10:29Z","timestamp":1790809829416,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["K24CA201543-01"],"award-info":[{"award-number":["K24CA201543-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jtho.2017.06.013","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T03:31:16Z","timestamp":1498102276000},"page":"1446-1450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0875-4731","authenticated-orcid":false,"given":"Arjun","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Saltarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier P.","family":"Scaglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2017.06.013_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tibs.2015.11.001","article-title":"Transport selectivity of nuclear pores, phase separation, and membraneless organelles","volume":"41","author":"Schmidt","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"10.1016\/j.jtho.2017.06.013_bib2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0092-8674(00)80361-X","article-title":"Nuclear export receptors: from importin to exportin","volume":"90","author":"Ullman","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jtho.2017.06.013_bib3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nature07975","article-title":"Structural basis for leucine-rich nuclear export signal recognition by CRM1","volume":"458","author":"Dong","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2017.06.013_bib4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1126\/science.1173388","article-title":"Crystal structure of the nuclear export receptor CRM1 in complex with Snurportin1 and RanGTP","volume":"324","author":"Monecke","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jtho.2017.06.013_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4255\/mcpharmacol.09.19","article-title":"RanGTPase: a key regulator of nucleocytoplasmic trafficking","volume":"1","author":"Lui","year":"2009","journal-title":"Mol Cell Pharmacol"},{"issue":"6","key":"10.1016\/j.jtho.2017.06.013_bib6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0092-8674(00)80370-0","article-title":"Exportin 1 (Crm1p) is an essential nuclear export factor","volume":"90","author":"Stade","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jtho.2017.06.013_bib7","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3892\/ijo.2016.3388","article-title":"Cellular apoptosis susceptibility (CAS) is overexpressed in thyroid carcinoma and maintains tumor cell growth: a potential link to the BRAFV600E mutation","volume":"48","author":"Holzer","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jtho.2017.06.013_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1515\/hsz-2012-0146","article-title":"Exportin t and exportin 5: tRNA and miRNA biogenesis\u2014and beyond","volume":"393","author":"Leisegang","year":"2012","journal-title":"Biol Chem"},{"key":"10.1016\/j.jtho.2017.06.013_bib9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/MCB.26.4.1318-1332.2006","article-title":"The mechanism of nuclear export of Smad3 involves exportin 4 and Ran","volume":"26","author":"Kurisaki","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jtho.2017.06.013_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ccr.2010.09.007","article-title":"A\u00a0genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells","volume":"18","author":"Melo","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2017.06.013_bib11","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1093\/emboj\/cdg565","article-title":"Exportin 6: a novel nuclear export receptor that is specific for profilin.actin complexes","volume":"22","author":"Stuven","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.jtho.2017.06.013_bib12","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1038\/sj.emboj.7600338","article-title":"Exportin 7 defines a novel general nuclear export pathway","volume":"23","author":"Mingot","year":"2004","journal-title":"EMBO J"},{"issue":"17","key":"10.1016\/j.jtho.2017.06.013_bib13","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1038\/emboj.2011.287","article-title":"Ran-dependent nuclear export mediators: a structural perspective","volume":"30","author":"Guttler","year":"2011","journal-title":"EMBO J"},{"issue":"26","key":"10.1016\/j.jtho.2017.06.013_bib14","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2174\/092986708786242859","article-title":"CRM1-mediated nuclear export of proteins and drug resistance in cancer","volume":"15","author":"Turner","year":"2008","journal-title":"Curr Med Chem"},{"issue":"6657","key":"10.1016\/j.jtho.2017.06.013_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/36894","article-title":"CRM1 is responsible for intracellular transport mediated by the nuclear export signal","volume":"390","author":"Fukuda","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2017.06.013_bib16","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/MCB.24.10.4395-4406.2004","article-title":"Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs","volume":"24","author":"Takenaka","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jtho.2017.06.013_bib17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bcp.2011.12.016","article-title":"Nuclear export of\u00a0proteins and drug resistance in cancer","volume":"83","author":"Turner","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jtho.2017.06.013_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.febslet.2004.08.056","article-title":"Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms","volume":"576","author":"Meissner","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtho.2017.06.013_bib19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/bjc.1996.415","article-title":"Phase I trial of elactocin","volume":"74","author":"Newlands","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2017.06.013_bib20","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood-2016-11-750158","article-title":"A\u00a0phase I clinical trial of single-agent selinexor in acute myeloid leukemia","volume":"129","author":"Garzon","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtho.2017.06.013_bib21","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1200\/JCO.2016.67.6346","article-title":"Phase IB study of selinexor, a first-in-class inhibitor of nuclear export, in patients with advanced refractory bone or soft tissue sarcoma","volume":"34","author":"Gounder","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.06.013_bib22","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2016-11-750174","article-title":"Selective inhibition of\u00a0nuclear export with selinexor in patients with non-Hodgkin's lymphoma","volume":"129","author":"Kuruvilla","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtho.2017.06.013_bib23","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2015.65.3949","article-title":"first-in-class, first-in-human phase i study of selinexor, a selective inhibitor of nuclear export, in patients with advanced solid tumors","volume":"34","author":"Abdul Razak","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.06.013_bib24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/JTO.0000000000000485","article-title":"Overexpression of CRM1: a characteristic feature in a transformed phenotype of lung carcinogenesis and a molecular target for lung cancer adjuvant therapy","volume":"10","author":"Gao","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.06.013_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/bjc.2014.260","article-title":"KPT-330 has antitumour activity against non-small cell lung cancer","volume":"111","author":"Sun","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2017.06.013_bib26","doi-asserted-by":"crossref","first-page":"e89848","DOI":"10.1371\/journal.pone.0089848","article-title":"Antitumor effects of\u00a0a novel chromosome region maintenance 1 (CRM1) inhibitor on non-small cell lung cancer cells in\u00a0vitro and in mouse tumor xenografts","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2017.06.013_bib27","doi-asserted-by":"crossref","first-page":"217304","DOI":"10.1155\/2015\/217304","article-title":"Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells","volume":"2015","author":"Cromie","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jtho.2017.06.013_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature19771","article-title":"XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer","volume":"538","author":"Kim","year":"2016","journal-title":"Nature"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417304665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417304665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T21:53:17Z","timestamp":1535752397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086417304665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1556086417304665"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2017.06.013","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2017.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}